• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Finance

Bacthera Acquires cGMP Manufacturing Site in León (ES) to Strengthen Clinical Supply Capacity

March 13, 2023 Microbiome Times

Basel, Switzerland, and Hørsholm, Denmark, March 13th 2023 – Bacthera, a specialized contract development and manufacturing organization (CDMO), announced today that it has acquired a cGMP manufacturing site in León (ES) from 4D Pharma. Acquiring […]

Pharma & Human Health

Gut bacteria are crucial for liver repair

March 10, 2023 Microbiome Times

When parts of the liver are removed, the body can replace the missing tissue. A team of researchers at the Technical University of Munich (TUM) has now discovered that the success of this process depends […]

Pharma & Human Health

University of Pittsburgh lab shows phage attacks in new light

March 8, 2023 Microbiome Times

As antibacterial resistance continues to render obsolete the use of some antibiotics, some have turned to bacteria-killing viruses to treat acute infections as well as some chronic illnesses. Graham Hatfull, the Eberly Family Professor of […]

Pharma & Human Health

Colorectal cancer surgery: Gut microbiota helps healing

March 8, 2023 Microbiome Times

Published in the journal Gut, the study by scientists at the CHUM Research Centre (CRCHUM) in Montreal identified two bacterial strains that directly affect whether or not anastomotic leakage, more commonly known as intestinal leakage, […]

Finance

Biose Industrie announces the opening of new manufacturing development facility in Boston, MA

March 2, 2023 Microbiome Times

Biose Industrie, a contract development manufacturing organisation (CDMO) and a world-leader of live biotherapeutic product (LBP) process development and production, announced today their plan to open a laboratory in the heart of Boston, Massachusetts, later […]

Finance

Biose Industrie to receive €80M in investment to boost workforce and manufacturing capabilities

February 17, 2023 Microbiome Times

L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a world leader in the development and production of […]

Pharma & Human Health

Regulatory pathway needs to be developed to make the most of phages

February 16, 2023 Microbiome Times

A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage […]

Finance

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

February 10, 2023 Microbiome Times

Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding. This follows Prokarium’s announcement of partnering with Ginkgo Bioworks to leverage its world-class Foundry and extensive Codebase […]

Finance

ADM Opens More Than $30 Million State-of-the-Art Production Facility in Spain

February 8, 2023 Microbiome Times

ADM (NYSE: ADM), one of the world’s leaders in science-backed nutrition solutions, announced that it has opened a new production facility in Valencia, Spain to help meet rising global demand for probiotics, postbiotics and other […]

Pharma & Human Health

Call for Experts – A Survey on Microbiome-Based Biomarker Development

February 7, 2023 Microbiome Times

The EU-funded coordination and support project “Human Microbiome Action” is seeking experts in microbiome-based biomarker development to partake in a Delphi survey. A Delphi Survey is a recognised research practice whereby experts reach a consensus […]

Pharma & Human Health

MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers

February 2, 2023 Microbiome Times

The University of Texas MD Anderson Cancer Center and Federation Bio, a biotechnology company pioneering bacterial cell therapies, today announced a strategic collaboration to design and manufacture a complex, synthetic microbial consortium with the goal […]

Posts navigation

« 1 … 17 18 19 … 77 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
  • DynaMAP – Precision Metagenomics beyond Sequencing
    May 27, 2025
  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
sign up

Sign up to the Microbiome Times newsletter